OMIC - Massive Insider Trade At Singular Genomics Sys | Benzinga
Eli Glezer, Chief Scientific Officer at Singular Genomics Sys (NASDAQ:OMIC), reported a large insider buy on November 20, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Glezer purchased 200,000 shares of Singular Genomics Sys. The total transaction amounted to $85,640.
Singular Genomics Sys shares are trading up 3.6% at $0.42 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing ...